INJEX Pharma AG, headquartered in Germany, is a pioneering company in the pharmaceutical and medical device industry, specialising in innovative drug delivery systems. Founded in 2006, INJEX has made significant strides in developing needle-free injection technology, which enhances patient comfort and compliance. The company’s flagship product, the INJEX 30, offers a unique solution for administering medications without needles, making it particularly appealing in the fields of diabetes management and vaccinations. With a strong presence in Europe and expanding operations globally, INJEX Pharma AG is recognised for its commitment to quality and innovation, positioning itself as a leader in the needle-free injection market. Notable achievements include various partnerships and collaborations aimed at advancing healthcare solutions, solidifying its reputation as a forward-thinking entity in the pharmaceutical landscape.
We don't have data for INJEX Pharma AG, but we can show you information about their parent organization instead.
View parent company